Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Amplify Weight Loss Drug & Treatment ETF doesn't have historical dividend data
FAQ
- What is THNR ETF?
- Does THNR pay dividends?
- What stocks are in THNR ETF?
- What is the current assets under management for THNR?
- What is THNR average volume?
- What is THNR expense ratio?
- What is THNR inception date?
What is THNR ETF?
THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.
Does THNR pay dividends?
No, the Amplify Weight Loss Drug & Treatment ETF doesn't pay dividends
What stocks are in THNR ETF?
As of today, Amplify Weight Loss Drug & Treatment ETF inlcudes 31 holdings, with 16 of them being companies from 8 different countries and 2 sectors. The most weighted holdings are Eli Lilly and Company (14.62%), Novo Nordisk A/S (13.43%) and Roche Holding AG (5.39%)
What is the current assets under management for THNR?
Assets under management of Amplify Weight Loss Drug & Treatment ETF is $3 M
What is THNR average volume?
Average volume of Amplify Weight Loss Drug & Treatment ETF is $7357
What is THNR expense ratio?
Expense ratio of Amplify Weight Loss Drug & Treatment ETF is 0.59%
What is THNR inception date?
null